$650 Million Settlement

March 7, 2016

The firm negotiated this settlement to resolve the claims of approximately 4,000 Pradaxa® users who claimed to have been injured by the drug. Risks associated with stroke among atrial fibrillation sufferers. Users utilizing Pradaxa started suffering bleeding by means of this medication. Boehringer Ingelheim Pharmaceuticals, Inc. including its affiliated businesses was driven by the Court to enter into a settlement with 4000 users of this anticoagulant that Napoli Shkolnik legal group was representing. Consequently, Boehringer Ingelheim consented To an amount of $650 million in settlement. Paul and his company ensured at least the wounded users of Pradaxa received warranted fiscal compensation and justice.
What is the Attorney-Client Privilege?

Every state in the Union recognizes and protects the attorney-client privilege. New York’s version of this privilege is in Civil Practice and Rules Section 5.03. The privilege applies...

Read the Article
Can You Sue a Doctor for Misdiagnosis?

If the misdiagnosis causes injury, then yes, you can sue a doctor for misdiagnosis. Medical misdiagnosis, mostly negative misdiagnosis, is the leading cause of medical malpractice claims. From...

Read the Article
NYC ‘Subway Surfing’ Death Prompts Civil Action

The MTA, Meta, and ByteDance Ltd. (TikTok) are jointly responsible for a rash of “subway surfing” deaths, according to court documents. Norma Nazario claims that countless videos on...

Read the Article
Contact Us:
Get a Free Case Evaluation Attorney Referral

Our Locations

Please Contact Us for an In-Person Appointment